Fenbendazole 222mg is gaining attention as a potential antiparasitic treatment for humans, though it is traditionally used in veterinary medicine. It belongs to the benzimidazole class of drugs and works by disrupting the energy metabolism of parasitic worms, leading to their elimination from the digestive system.
In humans, Fenbendazole 222mg is being used off-label under medical guidance to treat infections caused by roundworms, hookworms, whipworms, and other intestinal parasites. It is typically taken in short courses, such as 3–5 days, depending on the infection and body weight. The 222mg dose offers a convenient option for accurate and manageable administration.
While not yet FDA-approved for human use, many individuals report positive outcomes when used cautiously and with medical oversight. Some also explore its off-label use in cancer support protocols, though clinical evidence is still limited and ongoing.
Fenbendazole is generally well-tolerated, with mild side effects like nausea or stomach upset. Always consult a healthcare professional before use to ensure safety and appropriate dosage.